Results 41 to 50 of about 105,657,675 (250)
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben +4 more
wiley +1 more source
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk +10 more
wiley +1 more source
Developing an intuitive decision support system for equitable vaccine distribution during pandemics
Effective organization of the vaccine supply chain is vital to achieve high vaccination rates in pandemics. This paper presents a novel approach for developing a decision support system (DSS) to support health officials and policymakers who must make ...
Lise Boey +9 more
doaj +1 more source
Background Although they are declining worldwide, neurotropic parasitic diseases are still common in developing and emerging countries. The aim of this study was to estimate the pooled prevalence and pooled association measures of comorbidities between ...
Labanté Outcha Daré +6 more
doaj +1 more source
Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin +17 more
wiley +1 more source
Trading Away Access to Medicines - Revisited: How the European trade agenda continues to undermine access to medicines [PDF]
Insufficient innovation and a lack of access to affordable medicines are major barriers to achieving the right to health in low- and middle-income countries.
Mellema, Tessel +2 more
core
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann +8 more
wiley +1 more source
Trading Away Access to Medicines: How the European Union's trade agenda has taken a wrong turn [PDF]
Access to medicines poses a critical challenge in developing countries, largely because prices are high, and new or adapted medicines and vaccine to address diseases of the developing world are lacking.
Malpani, Rohit, Bloemen, Sophie
core
[Book Review] "A Human Rights Framework for Intellectual Property, Innovation and Access to Medicines" by Joo-Young Lee [PDF]
In the past year, there has been push by academics, scholars and policy-makers alike to re-situate the debate over access to medicines from the spheres of intellectual property, trade, and innovation policy to the context of human rights and public ...
Matthew Rimmer, Rimmer, Matthew
core +1 more source
Background The valuation of medicines as health needs vary depending on the stakeholders involved (users, prescribers, managers, etc.) and their expectations. These factors modulate the role of medicines as a health need and influence access to medicines,
Claudia Marcela Vargas-Pelaez +12 more
doaj +1 more source

